Erosive Osteoarthritis
7
0
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
14%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Methotrexate in Erosive Inflammatory Hand Osteoarthritis
Auricular Vagus Nerve Stimulation in Painful and Inflammatory Erosive Hand Osteoarthritis
A 30-month Follow-up of MERINO Participants to Evaluate Long-term Effects of Methotrexate in Erosive Hand OA.
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis
Treatment of Erosive Digital Osteoarthritis by Transcutaneous Auricular Nerve Stimulation
Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints